Skip to main content
letter
. 2011 May 5;96(7):1077–1078. doi: 10.3324/haematol.2011.043166

Figure 2.

Figure 2.

Screening clinical samples for BCR-ABL1 protein. (A) 157 cellular samples were screened for the presence of BCR-ABL1 protein; results are stratified by the BCR-ABL qRT-PCR results for the same sample. The MFI for each sample was determined as the observed MFI, minus the MFI value of the negative control plus two standard deviations. (B) 64 plasma samples were screened for the presence of the BCR-ABL1 protein. Fourteen from patients with neutrophilia and/or thrombocytosis or healthy controls normal plasma and 50 CML patients at diagnosis were studied.